Board to approve September 2026 quarterly and half-year results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
No financial figures are provided in this notice. The board will meet on 9 November 2026 to approve unaudited consolidated and standalone results for the quarter and half-year ended 30 September 2026, along with the limited review report. The trading window remains closed until 48 hours after results are declared.
Results are pending, so the notice gives shareholders no confirmed earnings, margin, cash flow or balance-sheet signal.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.